Article Text

Download PDFPDF
Demonstration of TGF-α–EGFR and EGF-EGFR autocrine loops and their relation to proliferation in complete hydatidiform moles (CHM)
  1. P. Balaram1,
  2. M. John1,
  3. S. Enose1 and
  4. P. K. Symaladevi2
  1. 1Regional Cancer Center, Trivandrum, Kerala, India;
  2. 2SAT Hospital for Women and Children, Trivandrum, Kerala, India
  1. Address correspondence and reprint requests to: Dr. Prabha Balaram, Additional Professor & Head, Research Division, Regional Cancer Center, Trivandrum 695 011, Kerala, India. E-mail: rcctvm{at}{at}


Complete hydatidiform moles (CHM) are the most common form of gestational trophoblastic disease. The prevalence rate is much higher in the state of Kerala, India, than in other parts of the world. The biology and role of growth factors are not fully understood in these tumors. In this study, we have immunohistochemically evaluated the expression of epidermal growth factor (EGF) and transforming growth factor alpha (TGF-α) along with their receptor, epidermal growth factor receptor (EGFR), and we have related them to the proliferative activity in normal placenta and CHM using the expression of proliferating cell nuclear antigen (PCNA) as the marker of proliferation. The results suggest activation of both EGF-EGFR and TGF-α–EGFR autocrine pathways in both types of tissues, with a predominance of the TGF-α–EGFR autocrine pathway in CHM. This is especially so in the more aggressive cases of CHM, the persisting group of diseases.

  • CHM
  • EGF
  • EGFR
  • persistence
  • placenta
  • TGF-α

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.